Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $31.2700 (0.87%) ($31.2700 - $31.2700) on Thu. Apr. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.84% (three month average) | RSI | 50 | Latest Price | $31.2700(0.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.6% a day on average for past five trading days. | Weekly Trend | IOVA advances 1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(41%) IWO(40%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.92% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.92% (StdDev 3.84%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $31.73 | 5 Day Moving Average | $31.7(-1.36%) | 10 Day Moving Average | $30.91(1.16%) | 20 Day Moving Average | $31.73(-1.45%) | To recent high | -40.6% | To recent low | 9.1% | Market Cap | $4.579b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |